Does the presence of cirrhosis influence on the mortality rate in patients with acute-on-chronic liver failure? APASL-ACLF Research Consortium study.

Phase 3

Completed

• Conditions: Presence of cirrhosis and its mortality influence in patients with acute- on- chronic liver failure; Cirrhosis; Acute- Chronic liver disease; Mortality rate; Prognosis

• Registration Number: TCTR20191226002
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-12-31
• Study Start: 2019-12-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1621

Inclusion Criteria

All adult patients, age above 18 years old, who were hospitalized from the emergency room or outpatient clinical due to having ACLF

Exclusion Criteria

decompensated cirrhosis, concomitant malignancy, pregnancy, severe co-morbidities (such as severe neurological deficit, poor cardiac function, chronic lung disease that limits activity in daily life, uncontrolled autoimmune diseases, etc.), chronic kidney disease and currently receive immunosuppressant

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate 28 days and 90 days Observation

Secondary Outcome Measures

Name	Time	Method
ength of hospital stay 90 days Observation